UnknownPhase 2NCT02353429

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

Studying Desmoid tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Principal Investigator
Chiara Colombo, MD
Fondazione IRCCS Istituto Tumori Milano
Intervention
Toremifene(drug)
Enrollment
25 enrolled
Eligibility
18 years · All sexes
Timeline
20122015

Study locations (1)

Collaborators

Associazione Italiana per la Ricerca sul Cancro

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02353429 on ClinicalTrials.gov

Other trials for Desmoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Desmoid tumor

← Back to all trials